The phenotypic spectrum of PCDH12 associated disorders - Five new cases and review of the literature

Walid Fazeli, Daniel Bamborschke, Abubakar Moawia, Somayeh Bakhtiari, Abbas Tafakhori, Matthias Giersdorf, Andreas Hahn, Anja Weik, Kirsten Kolzter, Sajad Shafiee, Sheng Chih Jin, Friederike Körber, Min Ae Lee-Kirsch, Hossein Darvish, Sebahattin Cirak, Michael C. Kruer, Anne Koy

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


PCDH12 is a member of the non-clustered protocadherin family of calcium-dependent cell adhesion proteins, which are involved in the regulation of brain development and endothelial adhesion. To date, only 15 families have been reported with PCDH12 associated disease. The main features previously associated with PCDH12 deficiency are developmental delay, movement disorder, epilepsy, microcephaly, visual impairment, midbrain malformations, and intracranial calcifications. Here, we report novel clinical features such as onset of epilepsy after infancy, episodes of transient developmental regression, and dysplasia of the medulla oblongata associated with three different novel truncating PCDH12 mutations in five cases (three children, two adults) from three unrelated families. Interestingly, our data suggests a clinical overlap with interferonopathies, and we show an elevated interferon score in two pediatric patients. This case series expands the genetic and phenotypic spectrum of PCDH12 associated diseases and highlights the broad clinical variability.

Original languageEnglish
Pages (from-to)7-13
Number of pages7
JournalEuropean Journal of Paediatric Neurology
StatePublished - Jan 2022


  • Brain malformation
  • Epilepsy
  • Interferonopathy
  • Intracranial calcification
  • Movement disorder
  • PCDH12


Dive into the research topics of 'The phenotypic spectrum of PCDH12 associated disorders - Five new cases and review of the literature'. Together they form a unique fingerprint.

Cite this